Dexcom reported third-quarter 2026 revenue of $1.344 billion, representing an 11% increase year-over-year, alongside GAAP operating income of $327.2 million. The company raised its full-year 2026 revenue guidance midpoint to between $5.20 billion and $5.25 billion and announced a new $1.0 billion share repurchase program. For shareholders, these results reflect continued top-line growth, margin expansion, and capital return initiatives.
Worldwide revenue grew 11% year-over-year to $1.344 billion for the third quarter ended September 30, 2026.
GAAP operating income reached $327.2 million, or 24.3% of revenue, compared to $242.5 million in the third quarter of 2025.
The Board of Directors authorized a share repurchase program of up to $1.0 billion of common stock expiring no later than December 31, 2027.
Full-year 2026 revenue guidance was raised to a range of $5.20 billion to $5.25 billion.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Dexcom's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$4.66B
+15.6%
$2.09
+47.2%
17.9%
FY2024
$4.03B
+11.3%
$1.42
+9.2%
14.3%
FY2023
$3.62B
+24.5%
$1.30
+58.5%
14.9%
FY2022
$2.91B
+18.8%
$0.82
+54.7%
11.7%
FY2021
$2.45B
+27.1%
$0.53
-60.2%
8.9%
Frequently asked questions
When is Dexcom's next earnings date?
Dexcom has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Dexcom earn last quarter?
For the quarter ended Sep 2026, Dexcom reported diluted EPS of $0.72 (+2.9% year over year) on revenue of $1.34B (+11.2%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.